352 related articles for article (PubMed ID: 18949388)
1. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.
Nakamuta M; Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Yada M; Yada R; Takemoto R; Fukuizumi K; Harada N; Taketomi A; Maehara Y; Nakashima M; Enjoji M
Int J Mol Med; 2008 Nov; 22(5):663-7. PubMed ID: 18949388
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
Nakamuta M; Kohjima M; Morizono S; Kotoh K; Yoshimoto T; Miyagi I; Enjoji M
Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.
Yeon JE; Choi KM; Baik SH; Kim KO; Lim HJ; Park KH; Kim JY; Park JJ; Kim JS; Bak YT; Byun KS; Lee CH
J Gastroenterol Hepatol; 2004 Jul; 19(7):799-804. PubMed ID: 15209628
[TBL] [Abstract][Full Text] [Related]
4. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
Yasutake K; Nakamuta M; Shima Y; Ohyama A; Masuda K; Haruta N; Fujino T; Aoyagi Y; Fukuizumi K; Yoshimoto T; Takemoto R; Miyahara T; Harada N; Hayata F; Nakashima M; Enjoji M
Scand J Gastroenterol; 2009; 44(4):471-7. PubMed ID: 19058085
[TBL] [Abstract][Full Text] [Related]
5. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
[TBL] [Abstract][Full Text] [Related]
6. A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
Takahashi N; Qi Y; Patel HR; Ahima RS
J Hepatol; 2004 Sep; 41(3):391-8. PubMed ID: 15336441
[TBL] [Abstract][Full Text] [Related]
7. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.
Baranova A; Gowder SJ; Schlauch K; Elariny H; Collantes R; Afendy A; Ong JP; Goodman Z; Chandhoke V; Younossi ZM
Obes Surg; 2006 Sep; 16(9):1118-25. PubMed ID: 16989692
[TBL] [Abstract][Full Text] [Related]
8. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
9. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease.
Younossi ZM; Baranova A; Ziegler K; Del Giacco L; Schlauch K; Born TL; Elariny H; Gorreta F; VanMeter A; Younoszai A; Ong JP; Goodman Z; Chandhoke V
Hepatology; 2005 Sep; 42(3):665-74. PubMed ID: 16116632
[TBL] [Abstract][Full Text] [Related]
10. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease.
Aller R; De Luis DA; Fernandez L; Calle F; Velayos B; Izaola O; Gonzalez Sagrado M; Conde R; Gonzalez JM
Eur Rev Med Pharmacol Sci; 2009; 13(5):357-64. PubMed ID: 19961041
[TBL] [Abstract][Full Text] [Related]
11. Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease.
Elizondo A; Araya J; Rodrigo R; Signorini C; Sgherri C; Comporti M; Poniachik J; Videla LA
Biol Res; 2008; 41(1):59-68. PubMed ID: 18769764
[TBL] [Abstract][Full Text] [Related]
12. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
[TBL] [Abstract][Full Text] [Related]
13. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
Tessari P; Coracina A; Cosma A; Tiengo A
Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
[TBL] [Abstract][Full Text] [Related]
14. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.
Westerbacka J; Kolak M; Kiviluoto T; Arkkila P; Sirén J; Hamsten A; Fisher RM; Yki-Järvinen H
Diabetes; 2007 Nov; 56(11):2759-65. PubMed ID: 17704301
[TBL] [Abstract][Full Text] [Related]
15. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model.
Matsunami T; Sato Y; Ariga S; Sato T; Shimomura T; Kashimura H; Hasegawa Y; Yukawa M
Metabolism; 2011 Jun; 60(6):805-14. PubMed ID: 20846698
[TBL] [Abstract][Full Text] [Related]
16. Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients.
Takamura T; Misu H; Matsuzawa-Nagata N; Sakurai M; Ota T; Shimizu A; Kurita S; Takeshita Y; Ando H; Honda M; Kaneko S
Obesity (Silver Spring); 2008 Dec; 16(12):2601-9. PubMed ID: 18846047
[TBL] [Abstract][Full Text] [Related]
17. Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients.
Lemoine M; Barbu V; Girard PM; Kim M; Bastard JP; Wendum D; Paye F; Housset C; Capeau J; Serfaty L
AIDS; 2006 Feb; 20(3):387-95. PubMed ID: 16439872
[TBL] [Abstract][Full Text] [Related]
18. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
Lee MS; Kim CT; Kim Y
Ann Nutr Metab; 2009; 54(2):151-7. PubMed ID: 19390166
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease.
Smith BW; Adams LA
Crit Rev Clin Lab Sci; 2011; 48(3):97-113. PubMed ID: 21875310
[TBL] [Abstract][Full Text] [Related]
20. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).
Musso G; Gambino R; Cassader M
Prog Lipid Res; 2009 Jan; 48(1):1-26. PubMed ID: 18824034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
